Bitcoin Depot Inc. (BTM)
(Delayed Data from NSDQ)
$1.73 USD
+0.02 (1.17%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.72 -0.01 (-0.58%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.73 USD
+0.02 (1.17%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.72 -0.01 (-0.58%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Zacks News
Bitcoin Depot Inc. (BTM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Bitcoin Depot Inc. (BTM) delivered earnings and revenue surprises of -533.33% and 9.81%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Lument Finance (LFT) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Lument (LFT) delivered earnings and revenue surprises of -18.18% and 3.03%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
AlTi Global, Inc. (ALTI) Reports Break-Even Earnings for Q2
by Zacks Equity Research
AlTi Global, Inc. (ALTI) delivered earnings and revenue surprises of 100% and 4.53%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Royalty Pharma (RPRX) delivered earnings and revenue surprises of 1.05% and 1.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Blue Owl Capital Corporation (OBDC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Blue Owl Capital Corporation (OBDC) delivered earnings and revenue surprises of 2.13% and 2.04%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Bitcoin Depot (BTM) Ahead of Earnings?
by Zacks Equity Research
Bitcoin Depot (BTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.